logo
Sri Ramakrishna Hospital's Gynecology Experts Urges Middle-aged Women to Prioritise Gynaecological Checkups for Early Detection of Hidden Health Risks

Sri Ramakrishna Hospital's Gynecology Experts Urges Middle-aged Women to Prioritise Gynaecological Checkups for Early Detection of Hidden Health Risks

As more women in their 40s and 50s overlook regular gynaecological visits, experts at Sri Ramakrishna Hospital warn that silent conditions like cervical cancer, osteoporosis, and hormonal imbalances may go unnoticed, impacting long-term health. The Gynecology experts shed light on the importance of prioritizing midlife reproductive health.
Best Gynecology Hospital in Coimbatore
Gynecological health often takes a back seat in midlife as women juggle career, family, and caregiving roles. However, skipping regular gynecological checkups during these crucial years can lead to missed early warning of serious health issues. Gynecology experts at Sri Ramakrishna Hospital urge women in their 40s and 50s to prioritize regular gynecological visits.
Midlife Brings Hormonal and Physical Changes – Monitoring Is Essential
From the late 30s to mid‐50s, women undergo significant hormonal transitions due to perimenopause and menopause. These changes affect everything, periods to mood, weight, skin, and reproductive organs. Regular checkups help us monitor these shifts and manage them before they impact overall wellbeing.
Menstrual irregularities, hot flashes, mood swings, weight gain, and changes in libido are just a few symptoms women may experience. While many of these are natural, some may point to underlying issues like uterine fibroids, endometriosis, or early menopause that need medical attention.
Catching Health Conditions Like Cancer Early – Screenings Matter
One of the strongest reasons not to skip a gynecological visit is the early detection of cancer. Cervical cancer is highly preventable and treatable when detected early through regular PAP smears and HPV tests. Unfortunately, many women stop screening after their childbearing years, thinking it's no longer necessary, which is a dangerous myth.
Ovarian cancer, often called the 'silent killer', shows few symptoms until it has progressed. Regular pelvic exams and ultrasounds during gynecological checkups can detect usual changes, leading to early diagnosis and a better chance of successful treatment.
Beyond Reproduction: Gynaecologists Monitor Overall Womens Healthy
Gynaecologists do more than assess reproductive health. At midlife, they evaluate a range of issues such as:
Bone health : Declining estrogen affects bone density, increasing the risk of osteoporosis.
Cardiovascular risk : Menopause raises the risk of heart disease in women.
Bladder issues : Urinary incontinence and recurrent infections are common in midlife and post-menopause.
Sexual health: Vaginal dryness, painful intercourse, and low libido can all be addressed with proper treatment.
Gynecology experts in Coimbatore take a holistic approach. They screen for common post-menopausal health concerns and work alongside endocrinologists, cardiologists, and other specialists to ensure overall wellness.
Mental Health and Hormonal Balance Are Interlinked
Many women report mood swings, anxiety, and even depressive symptoms as they enter menopause. Hormonal changes can significantly impact mental health, and regular gynaecological visits provide an opportunity to discuss these often-overlooked symptoms.
Be it assessing whether symptoms are hormonal or psychological in origin and guide patients towards the right treatments-be it hormone therapy, counselling, or lifestyle modifications, gynecology specialists in Coimbatore are at the forefront.
Routine Screenings Every Midlife Woman Shouldn't Miss
Pap Smear (every 3 years or as advised)
HPV Test
Breast Examination and Mammogram
Pelvic Ultrasound
Bone Density Test
Thyroid Function Tests
Blood Pressure and Diabetes Screening
These tests help us build a health profile that guides future care. If anything unusual is detected, the specialists can act early-whether it's fibroids, cysts, polyps, or hormonal imbalance.
Breaking the Stigma Around Gynaecological Health
One reason many midlife women avoid gynaecological checkups is stigma. Topics like urinary incontinence, hot flashes or abnormal bleeding are often swept under the rug due to embarrassment.
Sri Ramakrishna Hospital is committed to creating a judgement-free, compassionate space where women can talk openly and get accurate information. No concern is too small. Gynecologists encourage women to speak up about anything that feels off-because early detection saves lives.
The Role of Preventive Gynaecology in Healthy Aging
Preventive healthcare is a cornerstone of healthy aging. Regular gynaecological visits help maintain vitality and independence well into later life.
A lot of chronic issues we see in older women could have been avoided or better managed if they were caught during midlife. That's why it is stressed that preventive care rather than waiting for symptoms to become severe. Whether it's preventing prolapse, managing urinary leaks, or ensuring proper hormone balance, gynaecological support plays a key role in helping women age with confidence.
Midlife can be a powerful, transformative phase-if health is given its due attention. Skipping gynaecological checkups may seem harmless but can result in missed opportunities for early diagnosis, better health outcomes, and improved quality of life.
Gynecology experts at Sri Ramakrishna Hospital strongly advise all women above the age of 40 to make annual gynaecological checkups a priority-not just for reproductive health, but for overall wellness.
Sri Ramakrishna Hospital in Coimbatore has been at the forefront of womens healthcare for over four decades, offering expert-led, compassionate, and comprehensive gynaecological services. With a dedicated team of specialists, advanced diagnostic tools, and a patient-first approach, Sri Ramakrishna Hospital ensures that women at every stage of life-from adolescence to menopause-receive the care and attention they deserve.

Hashtags

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Oman to introduce HPV vaccine in school immunisation programme
Oman to introduce HPV vaccine in school immunisation programme

Muscat Daily

timean hour ago

  • Muscat Daily

Oman to introduce HPV vaccine in school immunisation programme

Muscat –Ministry of Health (MoH) will introduce the human papillomavirus (HPV) vaccine into the National School Immunisation Programme, targeting sixth-grade students in public and private schools across Oman. The move, which aligns with World Health Organization recommendations, marks a significant step in the country's efforts to prevent infectious diseases and reduce the long-term burden of cancer. HPV is one of the most common viral infections globally, linked to cervical cancer, cancers of the reproductive system in both women and men, and other related diseases. To prepare for the rollout, the Directorate General of Health Services in Musandam organised a workshop on Wednesday to raise awareness about the vaccine's benefits and train healthcare workers. Similar sessions will be held in other governorates to ensure smooth implementation. Badr bin Saif al Rawahi, Acting Director General of the Centre for Disease Control and Prevention, described the introduction of the vaccine as a 'strategic step towards enhancing public health and protecting future generations'. He noted that the programme will follow a phased plan designed in line with international best practices and national epidemiological data. Training for health workers will focus on vaccine administration, maintenance of the cold chain, distribution procedures, and community awareness. 'Equipping healthcare teams with the right skills and knowledge is essential to ensure safe delivery of the vaccine and build public confidence,' Rawahi said. The decision to include the HPV vaccine was endorsed by the National Technical Committee for Vaccines and Serums after a comprehensive review of local infection rates and an assessment of the vaccine's expected health and economic impact. MoH confirmed that the campaign will be conducted in cooperation with the Ministry of Education. Officials stressed that strengthening school-based immunisation is key to safeguarding the health of young people and further consolidating Oman's reputation as a regional leader in public health initiatives.

HPV vaccine to be included in school immunisation plan
HPV vaccine to be included in school immunisation plan

Times of Oman

time2 hours ago

  • Times of Oman

HPV vaccine to be included in school immunisation plan

Khasab: The Directorate General of Health Services in Musandam Governorate on Wednesday organised a workshop on the inclusion of the human papillomavirus (HPV) vaccine in the National School Immunisation Programme. The workshop is part of preparations for the national vaccination campaign, which aims to highlight national efforts in the field of student health and combating infectious diseases. The Ministry of Health intends to launch the human papillomavirus (HPV) vaccine as part of the National School Immunisation Programme for sixth-grade students in public and private schools. This decision is in line with the World Health Organization's evidence-based recommendations, which confirm the vaccine's effectiveness in preventing certain types of cancer, most notably cervical cancer, female and male reproductive system cancers, and other diseases directly linked to the virus. Bader Saif Al Rawahi, Acting Director General of the Centre for Disease Control and Prevention, said: 'Implementing this decision represents a strategic step towards enhancing public health and protecting future generations from the burden of infectious diseases.' He emphasised that the targeted groups will receive the vaccine according to a carefully considered phased plan based on national and international standards in this field. He added that the Ministry of Health is launching a series of training programmes for healthcare workers in Musandam Governorate, followed by other governorates. The programme aims to enhance their preparedness, enhance their knowledge and skills on vaccine administration, ensure adherence to approved standards for the cold chain and distribution.

What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?

Yahoo

time2 hours ago

  • Yahoo

What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?

Hologic HOLX is a leading name in the cytology space, with its Cytology business, part of its Diagnostics franchise, primarily focusing on screening for cervical cancer. The company has pioneered the first FDA-approved liquid-based cytology test — the ThinPrep Pap test — and the first FDA-approved mRNA-based HPV test — the Aptima HPV Assay. Co-testing — combining a Pap test with an HPV test — is the most sensitive testing option for cervical cancer screening compared to either test used alone. While this business of Hologic has historically been a flattish to single-digit grower, the company has continued to invest in it, like the 2024 launch of the Genius digital cytology system. It was a significant introduction, marking the only FDA-cleared digital cytology system that combines deep-learning-based AI with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells. HOLX management noted that if not for the sales headwinds in China, Cytology would have grown in low single digits in the second quarter of fiscal 2025, driven by the rollout of its Genius digital diagnostics system, instead of reporting a 2.2% decline. With more labs around the world implementing this in-house innovation, Hologic has received strong positive feedback. Genius replaces the traditional manual review of path slides, which was previously conducted on glass under a microscope, by capturing a digital image of the slide, which can be reviewed remotely from anywhere in the customer's network on the company's review station. These workflow advantages not only address their growing labor shortages but also enable cervical cancer screening in regions with limited infrastructure. Because the Genius system requires an overhaul of the traditional pet screening workflow, Hologic expects the full rollout to be a multi-year process, serving as a growth driver for the next several quarters. HOLX's Peers in Cervical Cancer Screening Quest Diagnostics DGX offers a complete menu of solutions for screening and diagnosing cervical cancer. In April this year, DGX introduced a new solution aimed at expanding access to human papillomavirus (HPV) screening to help identify women who are at risk of developing cervical cancer. With this new offering, physicians can offer patients the option to collect their specimen for HPV screening in a physician's office or other healthcare setting. Quest Diagnostics' latest test uses the FDA-cleared HPV self-collection solution from Roche, approved for use with Roche Holding AG's RHHBY cobas HPV test in May 2024. Roche's cervical cancer portfolio includes three clinically validated tests to help identify women at risk and improve the detection of high-grade disease in a single round of screening. The cobas HPV test is the first clinically validated, FDA-approved, CE-IVD marked HPV DNA test for all cervical screening indications — primary screening, ASC-US triage and co-testing. The CINtec PLUS Cytology test is the only FDA-approved triage test that uses dual biomarker technology to simultaneously detect p16 and Ki-67 in women with HPV-positive results. Roche's CINtec Histology test uses advanced p16 biomarker technology to confirm cervical lesions due to transforming HPV infections. HOLX Stock Performance, Valuation and Estimates In the past six months, Hologic shares have risen 5.2% against the industry's 11.9% fall. Image Source: Zacks Investment Research Hologic is trading at a forward three-year price-to-earnings of 15.23X, lower than the industry average of 28.67X. The stock carries a Value Score of B at present. Image Source: Zacks Investment Research Consensus estimates for Hologic's fiscal 2025 earnings are showing a mixed trend. Image Source: Zacks Investment Research HOLX stock currently carries a Zacks Rank #3 (Hold).You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Roche Holding AG (RHHBY) : Free Stock Analysis Report Quest Diagnostics Incorporated (DGX) : Free Stock Analysis Report Hologic, Inc. (HOLX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store